Riverhead Capital Management’s CONMED CNMD Stock Holding History

Riverhead Capital Management’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$338K	Hold	3,520	–	–	0.01%	900
2019 Q2	$301K	Hold	3,520	–	–	0.01%	960
2019 Q1	$293K	Hold	3,520	–	–	0.01%	954
2018 Q4	$226K	Hold	3,520	–	–	0.01%	1017
2018 Q3	$279K	Buy	3,520 +800	+29%	+$61.9K	0.01%	1037
2018 Q2	$199K	Hold	2,720	–	–	0.01%	1094
2018 Q1	$172K	Hold	2,720	–	–	0.01%	1137
2017 Q4	$139K	Buy	2,720 +500	+23%	+$26K	0.01%	1226
2017 Q3	$116K	Buy	2,220 +388	+21%	+$19.5K	0.01%	1233
2017 Q2	$93K	Buy	1,832 +932	+104%	+$46.1K	﹤0.01%	1246
2017 Q1	$40K	Sell	900 -200	-18%	-$8.6K	﹤0.01%	1318
2016 Q4	$49K	Hold	1,100	–	–	﹤0.01%	1240
2016 Q3	$44K	Sell	1,100 -1,276	-54%	-$54.2K	﹤0.01%	1221
2016 Q2	$29K	Sell	2,376 -3,249	-58%	-$138K	﹤0.01%	1380
2016 Q1	$236K	Sell	5,625 -1,875	-25%	-$73.6K	﹤0.01%	1200
2015 Q4	$330K	Buy	7,500 +5,200	+226%	+$226K	﹤0.01%	1107
2015 Q3	$110K	Buy	+2,300	New	+$126K	﹤0.01%	1038

Other funds holding CNMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Riverhead Capital Management's CNMD Position: Q3 2019 in Review

Riverhead Capital Management held its CONMED (CNMD) position steady in Q3 2019 at 3,520 shares worth $338K. The position accounts for 0.01% of the portfolio, ranked #900.

Riverhead Capital Management first reported a position in CNMD in Q3 2015 and has held it in 17 quarters since. 234 funds tracked by Wall St. Rank hold CNMD as of Q3 2019.

Riverhead Capital Management held 3,520 shares of CONMED worth $338K as of Q3 2019.
Riverhead Capital Management left its CONMED share count unchanged in Q3 2019.
CONMED made up 0.01% of Riverhead Capital Management's portfolio in Q3 2019, its #900 holding.
Riverhead Capital Management first reported a position in CONMED in Q3 2015 and has held it in 17 quarters since.
234 funds tracked by Wall St. Rank held CONMED as of Q3 2019.

Based on Riverhead Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.